ADVANCED HEALTH LIMITED - Trading Statement

Trading Statement

ADVANCED HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2013/059246/06)
(“the Company” or “Advanced Health”)
ISIN Code: ZAE000189049            
JSE Code: AVL


TRADING STATEMENT

In terms of paragraph 3.4(b)(i) of the Listings Requirements of the JSE Limited, listed companies are required
to publish a trading statement as soon as they become reasonably certain that the financial results for the
next period to be reported on will differ by more than 20% from those of the comparative period.

The directors of Advanced Health hereby advise shareholders that, in respect of the reviewed consolidated
results for the year ended 30 June 2022, the Company expects a loss per share of 4.04 cents which is an
improvement of 50.4% compared to the restated loss per share of 8.14 cents in the comparative period.

The headline loss per share for the year ended 30 June 2022 is expected to be 5.89 cents compared to the
headline loss per share of 6.82 cents in the comparative period, a 13.6% improvement in headline loss per
share.

The information in this trading statement has not been reviewed and reported on by the Company’s auditors.
Pretoria.

06 September 2022

Designated Advisor
Grindrod Bank Limited

Date: 06-09-2022 02:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.